The membrane-associated ubiquitin ligase MARCHF8 stabilizes the human papillomavirus oncoprotein E7 by degrading CUL1 and UBE2L3 in head and neck cancer

• DOI: 10.1128/jvi.01726-23
• Publication Date: 2024-01-16T14:00:34Z
• Authors: Mohamed I. Khalil; Canchai Yang; Lexi Vu; Smriti Chadha; Harrison Nabors; Claire D. James; Iain M. Morgan; Dohun Pyeon
• Keywords: Ubiquitin-Proteasome Proteolytic Pathway; Cell biology; E3 Ubiquitin Ligases; Ubiquitin-conjugating enzyme; Cancer research; Gene; Biochemistry; Article; Cullin; Biochemistry, Genetics and Molecular Biology; Health Sciences; Genetics; Molecular Biology; Biology; Gene knockdown; Ubiquitin; Life Sciences; The p53 Signaling Network in Cancer Research; 3. Good health; Virus-Cell Interactions; Ubiquitin ligase; Oncology; RNA Methylation and Modification in Gene Expression; FOS: Biological sciences; Medicine; Cell culture

Since human papillomavirus (HPV) oncoprotein E7 is essential for virus replication; HPV has to maintain high levels of E7 expression in HPV-infected cells. However, HPV E7 can be efficiently ubiquitinated by a ubiquitin ligase and degraded by proteasomes in the host cell. Mechanistically, the E3 ubiquitin ligase complex cullin 1 (CUL1) and ubiquitin-conjugating enzyme E2 L3 (UBE2L3) components play an essential role in E7 ubiquitination and degradation. Here, we show that the membrane ubiquitin ligase membrane-associated ring-CH-type finger 8 (MARCHF8) induced by HPV16 E6 stabilizes the E7 protein by degrading CUL1 and UBE2L3 and blocking E7 degradation through proteasomes. MARCHF8 knockout restores CUL1 and UBE2L3 expression, decreasing E7 protein levels and inhibiting the proliferation of HPV-positive cancer cells. Additionally, overexpression of CUL1 or UBE2L3 decreases E7 protein levels and suppresses in vivo tumor growth. Our results suggest that HPV16 maintains high E7 protein levels in the host cell by inducing MARCHF8, which may be critical for cell proliferation and tumorigenesis.